Early stage thymoma and the surgical extent paradigm

Gökhan Kocaman,Ayten Kayi Cangir
DOI: https://doi.org/10.1007/s13304-024-01918-z
2024-06-25
Updates in Surgery
Abstract:The recommended treatment for early stage thymoma without myasthenia gravis is complete thymectomy (CT). Limited thymectomy (LT) (simply resecting the thymoma with safe surgical margins) is gaining popularity. In this study, we compared the surgical and oncological results of complete and limited thymectomy in non-myasthenic patients with early stage thymoma. Non-myasthenic, Masaoka stage I–II, 86 patients who underwent surgical resection for thymoma were included in the study. Complete thymectomy (n:44) included patients who had resection of the thymoma together with the entire thymus and limited thymectomy (n:42) included patients who had resection of the thymoma without remaining thymus. The surgical approach, tumor size, histological type, pathological stage, adjuvant therapy, complications, postop myasthenia gravis, recurrence and death were recorded and compared between groups. Complete thymectomy group had more WHO type B1-3 tumors, more complications and more deaths than patients in the limited thymectomy group ( p = 0.03, 0.018 and 0.023 respectively). Although statistically not significant CT group had more recurrences than LT group (11.4%/4.8%, p = 0.43). The 10-year freedom from recurrence (FFR) rate in the CT group was 84.8% and in the LT group ıt was 97.6%, the difference was not statistically significant ( p = 0.15). None of the factors including surgical extent analysed with univariate and multivariate analysis had a significant effect on FFR. Limited thymectomy may be a good treatment option for non-myasthenic early stage thymoma patients but randomized controlled trials with long follow-up periods, ideally comparing patients operated with minimally invasive surgery are necessary.
surgery
What problem does this paper attempt to address?
The problem that this paper attempts to solve is about the best choice of surgical resection scope for early - stage thymoma (not accompanied by myasthenia gravis). Specifically, the study compared the surgical and oncological results of complete thymectomy (CT) and limited thymectomy (LT) in patients with early - stage thymoma without myasthenia gravis, especially the differences in recurrence rate, complications and the incidence of postoperative myasthenia gravis. ### Background Thymoma is the most common tumor in the anterior mediastinum of adults, although its incidence is low. For resectable cases, surgery is the main treatment option. The International Thymic Malignancy Interest Group (ITMIG) recommends complete thymectomy for thymoma patients without myasthenia gravis, that is, to remove the thymoma and the entire thymus. However, limited thymectomy (only removing the thymoma and preserving the remaining thymus) has gradually become popular. The study aims to evaluate the effects of these two surgical methods in patients with early - stage thymoma without myasthenia gravis. ### Research Objectives 1. **Compare the surgical results of complete thymectomy and limited thymectomy**: including surgical methods, tumor size, histological type, pathological stage, adjuvant treatment, complications, etc. 2. **Evaluate the oncological results of the two surgical methods**: especially the recurrence rate, the incidence of postoperative myasthenia gravis, survival rate, etc. 3. **Explore the impact of surgical scope on freedom from recurrence (FFR)**: through univariate and multivariate analyses, determine whether the surgical scope has a significant impact on FFR. ### Main Findings - **Surgical Results**: - There were more WHO type B1 - 3 tumors, more complications and a higher mortality rate in the complete thymectomy group (the p - values were 0.03, 0.018 and 0.023 respectively). - Although not statistically significant, the recurrence rate in the complete thymectomy group was slightly higher than that in the limited thymectomy group (11.4% vs 4.8%, p = 0.43). - **Oncological Results**: - The 10 - year recurrence - free survival rate (FFR) was 84.8% in the complete thymectomy group and 97.6% in the limited thymectomy group, and the difference was not statistically significant (p = 0.15). - Neither univariate nor multivariate analysis found that the surgical scope had a significant impact on FFR. ### Conclusion Limited thymectomy may be a good treatment option for patients with early - stage thymoma without myasthenia gravis, but more randomized controlled trials and long - term follow - up are needed for further verification. In particular, randomized controlled trials comparing minimally invasive surgery patients will help to better evaluate the effects of these two surgical methods.